Protein interactions mediated by the product of the tumour suppressor gene neurofibromatosis type 2

Protein interactions mediated by the product of the tumour suppressor gene neurofibromatosis type 2

Bibliographic Details
Main Author:	Neill, Graham William
Published:	Institute of Cancer Research (University Of London) 1999
Subjects:	610 Medicine
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.369248

Similar Items

Mapping of putative tumour suppressor genes in epithelial ovarian cancer
by: Martin, Rosalind J. L.
Published: (1998)

Proto-oncogene and tumour suppressor gene expression in normal and abnormal growth with emphasis on neuroendocrine tumours
by: Roncalli, Massimo
Published: (1995)

Regulation of complex formation between the tumour suppressor protein p53 and SV40 large T antigen
by: Kernohan, Neil M.
Published: (1998)

The role of fat tumour suppressor gene
by: Patel, Anjla Chhotubhai
Published: (2003)

Biophysical characterization of tumour suppressor p53 and its protein-interaction network
by: Rajagopalan, Sridharan
Published: (2010)

Studies of the p53 tumour suppressor gene and related proteins in cytopathology
by: Dowell, Stephanie Patricia
Published: (1996)

N terminal and DNA binding domain interactions of tumour suppressor protein p53
by: Baloglu, Cetin
Published: (2010)

Identification and characterisation of candidate tumour suppressor genes from chromosome 13q14.3, an area of frequent deletion in patients with B-cell chronic lymphocytic leukaemia
by: Rowntree, Clare Judith
Published: (2000)

Pathology of tumour cell host interactions
by: Horak, E.
Published: (1986)

Cell-mediated immunity to carcinogen-induced rat tumours
by: Jones, J. A.
Published: (1980)

Cytotoxicity mediated by monoclonal antibodies to tumour associated antigens
by: Dullforce, Per
Published: (1991)

The role of the Wilms tumour suppressor gene (WTI) during human decidualization
by: Lucas, Christopher H.
Published: (2010)

The vascularization of solid tumours : mathematical models of tumour angiogenesis and vascular tumour growth
by: Orme, Michelle Elaine
Published: (1996)

Thermodynamic analysis of the stability of the tumour suppressor, p53
by: Khoo, Kian Hoe
Published: (2010)

Investigating the role of the secreted tumour suppressor Dickkopf-3 in stromal-epithelial interactions in prostate cancer
by: Al-Shareef, Zainab
Published: (2017)

On fibrinolysis and malignancy : studies of tissue plasminogen activators in carcinoma of the breast and in a murine tumour
by: Layer, Graham Tansley
Published: (1990)

Molecular and functional identification of tumour suppression genes involved in mouse skin carcinogenesis
by: Frame, Sheelagh
Published: (1997)

An immunohistological study of benign eccrine sweat gland tumours
by: Cotton, Dennis William Keith
Published: (1987)

Expression of oncogenes and a breast cancer associated protein, pS2, in human neuroendocrine tumours : implication for tumourigenesis
by: Wang, Da-Gong
Published: (1996)

In vitro study of tumour associated opiate receptors and tumour derived opioid activity
by: Gusterson, B. A.
Published: (1980)

A study of suppressor cells in enhanced organ allografts
by: Hendry, W. S.
Published: (1981)

Endocrinology, oncogene and tumour suppressor gene expression in Barrett's oesophagus, oesophageal and gastric cardia carcinoma
by: Ritchie, Andrew John
Published: (1993)

Extracellular matrix interactions in ovarian cancer : an investigation into the role of integrins and matrix metalloproteinases in ovarian tumour progression
by: Afzal, Saliha
Published: (1998)

Interaction of plasma proteins especially fibrin and its degradation products in the production of proliferative atherosclerotic lesions
by: Stirk, Christina M.
Published: (1992)

An investigation of the interactions of the herpes simplex virus type 1 immediate-early protein Vmw110 with cellular proteins
by: Meredith, Michayla Robyn
Published: (1996)

Erthropoietin, anaemia and tumour hypoxia
by: MacManus, Michael Patrick
Published: (1989)

Molecular analysis of ovarian tumours
by: Bell, Daphne Winifred
Published: (1991)

Experimental studies on tumour angiogenesis
by: Fraser, R. Ashley
Published: (1983)

Suppressor cell function in normal individuals and patients with lymphoproliferative disease
by: Akbar, A. N.
Published: (1982)

Role of the VHL and PTEN tumour suppressors in clear cell renal carcinoma
by: Barod, R.
Published: (2011)

Functional analysis of the Neurofibromatosis Type II tumor suppressor gene
by: Shaw, Reuben J. (Reuben James), 1972-
Published: (2014)

Structural and biophysical studies on the tumour suppressor p53 and its regulator ASPP2
by: Tidow, Henning
Published: (2008)

Evolution and origin of merlin, the product of the <it>Neurofibromatosis type 2 </it>(<it>NF2</it>) tumor-suppressor gene
by: Omelyanchuk Leonid V, et al.
Published: (2005-12-01)

Methylation of the tumour suppressor genes p16 and RB1 and their role in the tumorigenesis of sporadic pituitary adenomas
by: Simpson, David John
Published: (2001)

Phenomenon of heterogenisation of tumour cells with tuberculin
by: Vyakarnam, A.
Published: (1981)

Carbohydrate antigens associated with gastrointestinal tumours
by: Brown, A.
Published: (1984)

Augmentation of immune responses to experimental tumours
by: Basley, W. A.
Published: (1980)

Radiolabelling of antibodies for tumour diagnosis and therapy
by: Jolley, Clive Joseph
Published: (1993)

Factors affecting formation and distribution of metastatic tumour deposits after vascular dissemination of cells from spontaneous tumours
by: Juacaba, S. F.
Published: (1984)

Why the tumour suppressor p53 is a tetramer
by: Natan, Eviatar
Published: (2011)